Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

Acquisition

5 Oct 2021 07:00

RNS Number : 0307O
IDOX PLC
05 October 2021
 

5 October 2021

 

Idox plc

('Idox' or the 'Group' or the 'Company')

 

Acquisition

 

Idox acquires exeGesIS, a GIS software business

 

ldox plc (AIM: IDOX), a leading supplier of specialist information management software and solutions to the public and asset-intensive sectors, is pleased to announce the acquisition of exeGesIS Spatial Data Management Ltd ("exeGesIS"), a UK based geospatial information services (GIS) technology business.

Highlights

· Further enhances Idox's GIS capabilities following the recent purchase of thinkWhere

· Initial cash consideration is £5.35m

· Strong margins and recurring revenues

· Immediately earnings enhancing

Consideration

The initial cash consideration for the acquisition is £5.35m, with up to £1.65m of additional cash consideration deferred for 12 months, contingent on the retention of existing recurring revenues. The consideration will be funded from Idox's existing financial resources.

About exeGesIS

Based in Brecon, Wales, exeGesIS provides both public and private sectors software which helps collect information and manage assets of ecological, environmental and historical importance. The company works with private organisations, local authorities and other public sector bodies who manage public rights-of-way, archaeological sites, historic assets, conservation areas and nature reserves. This customer base is complementary to Idox's and brings a number of new clients into the Group.

Employing 35 people, exeGesIS is highly regarded within the geo spatial sector, providing a range of GIS focused software solutions. Director Crispin Flower will join Idox in a new role leading the GIS function with the remaining management team exiting the business following an integration plan planned to span a six-month period.

Strengthening Idox's presence in an attractive new sector

Idox views the GIS sector as an attractive, high growth adjacency and has placed an increased focus on its GIS capabilities recently, notably with the purchase of thinkWhere in August 2021. The acquisition of exeGesIS will considerably improve Idox's product offering, specifically within the land and property sector. The established mapping technologies and knowledge within exeGesIS will enable Idox to provide much needed data and services that allow for location visualisation which is an emerging requirement across a number of land and property industries.

This acquisition provides Idox with the opportunity to enhance our GIS offerings, notably to help build on the management and recording of data on emissions and land usage. This enhanced GIS offering is crucial, especially as environmental issues remain high on the global agenda.

The acquisition is expected to be immediately earnings enhancing and the Board believes there is scope to deliver attractive profit growth over the medium term through a range of commercial synergies.

David Meaden, CEO of Idox commented:

"As Idox continues to build on its GIS, mapping and data capabilities, the acquisition of exeGesIS is an exciting move and allows us to offer greater expertise, products and services to our customers. The addition of the exeGesIS products to our current offering will provide customers and users the opportunity to benefit from a single supplier relationship and extended capabilities."

"The integration of this business, coupled with the recent acquisition of thinkWhere, will place Idox in a strong position to capitalise on the growth of the UK's location data market. This transaction will provide further support to the exeGesIS business and products so that it can continue to grow both domestically and internationally."

Notes:

For the year ended 30 April 2020, exeGesIS reported revenues of £2.8m and PBT of £0.8m. Gross assets at 30 April 2020 were £2.3m. exeGesIS is majority owned and controlled, directly and indirectly via connected persons, by two directors James Perrins and Anthony Pettitt, and one employee Paul Mills.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

The person responsible for making this notification is Ruth Paterson, Company Secretary.

-Ends-

Enquiries:

Idox plc +44 (0) 870 333 7101

Chris Stone, Non-Executive ChairmanDavid Meaden, Chief ExecutiveRob Grubb, Chief Financial OfficerPeel Hunt LLP (NOMAD and Broker) +44 (0) 20 7418 8900Edward KnightPaul GillamNick ProwtingMHP Communications +44 (0) 203 128 8170Reg Hoare / James Bavister / Alex Janiaud idox@mhpc.com 

About Idox plc

For more information see www.idoxplc.com @Idoxgroup

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQMABATMTBMMJB
Date   Source Headline
19th Feb 20217:39 amRNSStatement re Possible Offer
19th Feb 20217:00 amRNSStatement re Possible Offer
3rd Feb 20217:00 amRNSAGM Date & Dividend Payment Schedule
2nd Feb 20217:00 amRNSFY20 Results
19th Jan 20214:05 pmRNSExercise of Share Options & Total Voting Rights
19th Jan 20217:00 amRNSNotice of Final Results
2nd Dec 20207:00 amRNSContract Win
2nd Dec 20207:00 amRNSExercise of Share Options and Total Voting Rights
26th Nov 202011:37 amRNSInvestor presentation
17th Nov 20207:00 amRNSYear End Trading Update
27th Oct 20207:00 amRNSExercise of Share Options & Total Voting Rights
22nd Oct 20205:35 pmRNSHolding(s) in Company
21st Oct 20207:00 amRNSAppointment of Head of Professional Services
14th Oct 20205:45 pmRNSReplacement: Exercise of Share Options & TVR
14th Oct 202011:51 amRNSHolding(s) in Company
14th Oct 20207:00 amRNSIdox Rebrand and Recent Progress with Idox Cloud
13th Oct 20207:00 amRNSExercise of Share Options & Total Voting Rights
23rd Sep 20205:30 pmRNSHolding(s) in Company
28th Aug 20207:00 amRNSDirectorate Changes
25th Aug 20207:00 amRNSExercise of Share Options & Total Voting Rights
16th Jul 20207:00 amRNSExercise of Share Options & Total Voting Rights
8th Jul 20201:58 pmRNSHolding(s) in Company
19th Jun 20207:00 amRNSGrant of Options
15th Jun 20207:00 amRNSHalf-year Report
28th May 202011:18 amRNSResult of AGM
19th May 20207:00 amRNSHalf Year Trading Update
1st May 20207:42 amRNSPosting of Annual Report and Notice of AGM
28th Apr 20204:33 pmRNSHolding(s) in Company
20th Apr 20208:01 amRNSProgressive publishes new research
14th Apr 20207:01 amRNSDirectorate Change
14th Apr 20207:00 amRNSFinal Results
30th Mar 20204:36 pmRNSPrice Monitoring Extension
23rd Mar 20207:00 amRNSNotice of Results Update
16th Mar 20207:00 amRNSTrading Update and Notice of Results update
7th Feb 202011:33 amRNSHolding(s) in Company
7th Feb 202011:29 amRNSNotice of Results
23rd Jan 20207:00 amRNSChange of Adviser and Notice of Results
22nd Jan 202012:44 pmRNSAIM Rule 17 Schedule Two (g) Update
17th Jan 202012:12 pmRNSDirectors' Dealings & Holdings in Company
3rd Jan 20207:00 amRNSDirectors' Dealings & Holdings in Company
24th Dec 201912:49 pmRNSDirectors' Dealings & Holdings in Company
19th Dec 20197:00 amRNSNew Banking Facilities
2nd Dec 20192:45 pmRNSDirectors' Dealings & Holdings in Company
27th Nov 20192:54 pmRNSDirectors' Dealings & Holdings in Company
27th Nov 20192:10 pmRNSHolding(s) in Company
27th Nov 20192:08 pmRNSHolding(s) in Company
25th Nov 20197:00 amRNSYear End Trading Update
3rd Oct 20192:09 pmRNSExercise of Share Options & Total Voting Rights
17th Sep 20193:03 pmRNSHolding(s) in Company
30th Aug 201910:02 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.